KKR & CO INC (KKR)

US48251W1045 - Common Stock

157.67  +5.49 (+3.61%)

After market: 160 +2.33 (+1.48%)

News Image
7 hours ago - Bloomberg

KKR-Bain Brawl Worth $4 Billion Shows Japan Private Equity Boom

When KKR & Co. offered almost $4 billion for a Japanese IT consulting company back in August, the proposal generated buzz in the country’s burgeoning buyout market.

News Image
4 days ago - Bloomberg

Wall Street Bankers Spot a Fat Payday in $1 Trillion AI Hysteria

Finance’s marquee names are ready to gatecrash the artificial-intelligence party.

News Image
8 days ago - Instructure

KKR and Dragoneer Complete Acquisition of Instructure

/PRNewswire/ -- Instructure Holdings, Inc. ("Instructure"), a leading learning ecosystem, today announced the close of its acquisition by investment funds...

News Image
10 days ago - Bloomberg

KKR-Owned PR Firm Hires McKinsey to Advise on Growth Strategy

FGS Global, which grew into one of the world’s biggest corporate communications firms through a series of mergers, has hired management consultancy McKinsey & Co. to advise on its growth strategy as KKR & Co. nears completion of its takeover.

News Image
15 days ago - Investor's Business Daily

Equitable Holdings Joins Elite Club Of Top Stocks

Equitable stock nearly doubled is just over a year, rising from a 24.65 intraday low on Nov. 1, 2023 to trade at about 48.95 Thursday. 

News Image
15 days ago - FS Investments

FS KKR Capital Corp. Announces Third Quarter 2024 Results

/PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), or the Company, today announced its financial and operating results for the quarter ended September 30, 2024,...

News Image
16 days ago - Bloomberg

KKR Is Said to Consider Selling $750 Million Stake in JB Pharma

KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in the market, according to people familiar with the matter.

News Image
16 days ago - Bloomberg

NielsenIQ Considers an IPO at a Valuation Close to $10 Billion

NielsenIQ is exploring an initial public offering that could value the consumer intelligence firm at about $10 billion, according to people familiar with the matter, as the market for first-time share sales continues a comeback.

News Image
17 days ago - Bloomberg

KKR Gets Over Third of Fuji Soft After Tender Offer First Stage

KKR & Co. has secured more than one-third of Fuji Soft Inc. after the private equity firm completed the first stage of its tender offer, according to people familiar with the matter.

News Image
18 days ago - Chartmill

Is NYSE:KKR a Fit for high Growth Investing Strategies?

Should you consider KKR & CO INC (NYSE:KKR) for high growth investing?

News Image
21 days ago - Bloomberg

KKR Sees $250 Billion of Annual Spending From Data-Center Boom

Soaring demand for data centers to support artificial intelligence and cloud-computing will boost global spending in the sector to $250 billion a year, according to KKR & Co.

News Image
22 days ago - Bloomberg

KKR’s $20 Billion Goal Tests Investor Appetite for Buyout Funds

Private equity pioneer KKR & Co. is testing whether investors still crave the asset class after more than two years of sluggish dealmaking squeezed returns across the industry.

News Image
23 days ago - Bloomberg

KKR and Energy Capital Partners Form $50 Billion AI Partnership

KKR & Co. and Energy Capital Partners agreed to a $50 billion partnership to accelerate the development of infrastructure for artificial intelligence.

News Image
23 days ago - Bloomberg

Apollo Founder Harris Says Big PE Firms Have Left Alpha Behind

26North Partners founder Josh Harris said he started his firm to bring big, market-beating returns back to alternative asset management.

News Image
24 days ago - Capital Group Companies

Capital Group and KKR Advance Public-Private Investment Solutions for Individual Investors

/PRNewswire/ -- Leading global investment firms Capital Group and KKR today filed registration statements with the SEC for two public-private fixed income...

News Image
24 days ago - Resolian

Resolian Appoints Rob Stachlewitz as CEO, Honggang Bi as Chairman of the Board, and Pat Bennett as Chief Business Officer and President of Scientific Affairs

/PRNewswire/ -- Resolian, a leading global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, today...